Prostate cancer specialists at the University of Michigan Comprehensive Cancer Center are refining prostate cancer diagnosis to better identify those cancers that are more likely to grow quickly and spread to other parts of the body.
Daniel F. Hayes, M.D., clinical director of the breast oncology program at the University of Michigan Comprehensive Cancer Center, was elected president of the American Society of Clinical Oncology, the largest and one of the most influential oncology professional societies.
Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival, according to a new study from the University of Michigan Comprehensive Cancer Center.
What’s the best way to treat rectal cancer? Consult any of five top clinical guidelines for rectal cancer and you will get a different answer, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
Patients who were told they had a 1-in-10 chance of winning $50 were more likely to complete home stool blood tests that help screen for colon cancer, according to a new study led by a researcher at the VA Ann Arbor Healthcare System and University of Michigan. The findings appear in a special issue of Annals of Internal Medicine.
The Centers for Medicare and Medicaid announced Monday that lung cancer screening with CT scans will be covered for people at high-risk of developing lung cancer. The decision includes requirements to ensure quality and safety.
Report card on complementary therapies for breast cancer: Meditation, yoga get ‘A’ for easing anxiety, mood
New guidelines based on decades of clinical trials give guidance about which complementary therapies appear to be most effective and safe for breast cancer patients. More than 80 therapies were evaluated and assigned a letter grade.
The University of Michigan men’s ice hockey team, in partnership with the University of Michigan Health System and the Movember Foundation, announced the second annual Michigan Moustaches for Men’s Health initiative during the month of November.
A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.
Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. The burden was greatest among patients who received chemotherapy.